Literature DB >> 17267479

Bluetongue virus entry into cells.

Mario Forzan1, Mark Marsh, Polly Roy.   

Abstract

Bluetongue virus (BTV) is a member of the Orbivirus genus within the Reoviridae family. Like those of other members of the family, BTV particles are nonenveloped and contain two distinct capsids, namely, an outer capsid and an inner capsid or core. The two outer capsid proteins, VP2 and VP5, are involved in BTV entry into cells and in the delivery of the transcriptionally active core to the target cell cytoplasm. However, very little is known about the precise mechanism of BTV entry. In this report, using RNA interference, we demonstrate that inhibition of the clathrin-dependent endocytic pathway correlates with reduced BTV internalization and subsequent replication. Furthermore, by using the ATPase inhibitor bafilomycin A1, we show that exposure of the virus to acidic pH is required for productive infection. Moreover, microscopic analysis of cells incubated with BTV indicated that the virus is internalized into early endosomes, where separation of the outer capsid and inner core occurs. Together, our data indicate that BTV undergoes low-pH-induced penetration in early endosomes following clathrin-mediated endocytosis from the plasma membrane, supporting a stepwise model for BTV entry and penetration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267479      PMCID: PMC1900141          DOI: 10.1128/JVI.02284-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes.

Authors:  M Rubino; M Miaczynska; R Lippé; M Zerial
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 2.  Clathrin-dependent or not: is it still the question?

Authors:  Ludger Johannes; Christophe Lamaze
Journal:  Traffic       Date:  2002-07       Impact factor: 6.215

Review 3.  Endocytosis via caveolae.

Authors:  Lucas Pelkmans; Ari Helenius
Journal:  Traffic       Date:  2002-05       Impact factor: 6.215

4.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.

Authors:  S S Hassan; P Roy
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

Authors:  M T Pho; A Ashok; W J Atwood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization.

Authors:  S H Hassan; C Wirblich; M Forzan; P Roy
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

View more
  45 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

2.  Structural insight into African horsesickness virus infection.

Authors:  Violeta Manole; Pasi Laurinmäki; Wouter Van Wyngaardt; Christiaan A Potgieter; Isabella M Wright; Gert J Venter; Alberdina A van Dijk; B Trevor Sewell; Sarah J Butcher
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 3.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

Review 4.  Elucidating virus entry using a tetracysteine-tagged virus.

Authors:  Bjorn-Patrick Mohl; Polly Roy
Journal:  Methods       Date:  2017-08-09       Impact factor: 3.608

5.  Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.

Authors:  Junzheng Du; Bishnupriya Bhattacharya; Theresa H Ward; Polly Roy
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

6.  Development of an insect vector cell culture and RNA interference system to investigate the functional role of fijivirus replication protein.

Authors:  Dongsheng Jia; Hongyan Chen; Ailing Zheng; Qian Chen; Qifei Liu; Lianhui Xie; Zujian Wu; Taiyun Wei
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Endosomes and Microtubles are Required for Productive Infection in Aquareovirus.

Authors:  Fuxian Zhang; Hong Guo; Qingxiu Chen; Zheng Ruan; Qin Fang
Journal:  Virol Sin       Date:  2019-12-19       Impact factor: 4.327

8.  In situ structures of RNA-dependent RNA polymerase inside bluetongue virus before and after uncoating.

Authors:  Yao He; Sakar Shivakoti; Ke Ding; Yanxiang Cui; Polly Roy; Z Hong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-26       Impact factor: 11.205

9.  Endocytic uptake pathways utilized by CPMV nanoparticles.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Mol Pharm       Date:  2012-09-20       Impact factor: 4.939

10.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.